Author Contributions: Drs Albert and Fonarow had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Albert, Yancy, Cannon, Fonarow.
Acquisition of data: Albert, Fonarow.
Analysis and interpretation of data: Albert, Liang, Zhao, Hernandez, Peterson, Fonarow.
Drafting of the manuscript: Albert, Fonarow.
Critical revision of the manuscript for important intellectual content: Albert, Yancy, Liang, Zhao, Hernandez, Peterson, Cannon, Fonarow.
Statistical analysis: Liang, Zhao, Peterson.
Obtained funding: Peterson, Cannon, Fonarow.
Administrative, technical, or material support: Albert, Hernandez, Cannon, Fonarow.
Study supervision: Albert, Yancy, Cannon, Fonarow.
Financial Disclosures: Dr Albert reported serving on the speakers bureau of GlaxoSmithKline, Medtronic, Nitromed, and Scios (since 2004; speakers bureau relationships with Nitromed, Medtronic, and Scios ended in 2007); serving as a consultant for Arca biopharma (2008); and currently serving as a consultant for Medtronic, Merck, and Impedance Cardiology Systems Inc. Dr Yancy reported receiving research grants from GlaxoSmithKline, Medtronic, NitroMed, and Scios (since 2004); previously serving as a consultant for or on the speakers bureau of Astella, AstraZeneca, GlaxoSmithKline, Medtronic, NitroMed, Novartis, Otsuka, and Scios; previously serving on the advisory board for CHF Solutions (all of these relationships expired prior to 2007); serving on the advisory board for ARCA Discovery and receiving additional research support from GlaxoSmithKline, Medtronic, and Thoratec Inc (all of which have expired or represent uncompensated work as of June 2008); currently serving on the US Food and Drug Administration cardiovascular device panel and study section for the National Institutes of Health; and holding an editorial position with the American Journal of Cardiology and serving on several other editorial boards. Dr Hernandez reported receiving research grants from GlaxoSmithKline, Johnson & Johnson (Scios Inc), Medtronic, Merck, and Roche Diagnostics; and serving on the speakers bureau for or receiving honoraria within the past 5 years from AstraZeneca, Medtronic, Novartis, Sanofi-Aventis, and Thoratec Corporation; Dr Hernandez has made detailed listings of financial disclosures available online at http://www.dcri.duke.edu/research/coi.jsp. Dr Peterson reported serving as the principal investigator for the American Heart Assocation Get With The Guidelines data analytic center at the Duke Clinical Research Institute; receiving a research grant from BMS/Sanofi; and previously serving on an advisory board for Pfizer and as a consultant for Eli Lilly; Dr Peterson has made detailed listings of financial disclosures available online at http://www.dcri.duke.edu/research/coi.jsp. Dr Cannon reported receiving research grants/support from Accumetrics, AstraZeneca, Bristol-Myers Squibb/Sanofi Partnership, GlaxoSmithKline, Intekrin, Merck, Merck/Schering-Plough Partnership, Novartis, and Takeda; and serving as a clinical advisor with equity in Automedics Medical Systems. Dr Fonarow reported receiving research grants or other research support from GlaxoSmithKline, Pfizer, and the National Institutes of Health; receiving honoraria from Amgen, AstraZeneca, Boston Scientific/Guidant, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Schering-Plough, and St Jude Medical; serving as a consultant for ARCA, Boston Scientific/Guidant, DebioPharm, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Relypsa, Scios, and St Jude Medical; and serving as chair of the American Heart Association Get With The Guidelines Steering Committee;. Dr Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine at UCLA and is also supported by the Ahmanson Foundation (Los Angeles, California). No other authors reported disclosures.
Funding/Support: The Get With The Guidelines–Heart Failure program is sponsored by the American Heart Association and receives funding in part from GlaxoSmithKline and Medtronic.
Role of the Sponsors: GlaxoSmithKline and Medtronic had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.
Disclaimer: Dr Peterson, a contributing editor for JAMA, was not involved in the editorial review of or the decision to publish this article.